These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 4617835)

  • 1. [Treatment of chronic arterial vascular disorders with Complamin and Complamin retard].
    Musil HE
    Med Welt; 1973 Jan; 24(3):103-13. PubMed ID: 4617835
    [No Abstract]   [Full Text] [Related]  

  • 2. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
    Spinella G; Majorana M
    Clin Ter; 1983 Mar; 104(5):375-81. PubMed ID: 6303677
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trial of xanthinol nicotinate in delayed form in the treatment of arteritis of the lower limbs].
    Niquet G; Dupont T
    Lille Med; 1976 Jan; 21(1 suppl 1):13-5. PubMed ID: 1256225
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs].
    Raspanti D; Cameli AM; Trapani M; Dorigo D; Mazzotta A; Negro P
    Clin Ter; 1987 Jun; 121(6):479-83. PubMed ID: 2973884
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of Xavin infusions in obliterating peripheral arterial disorders.
    Keller L; Landi A; Bársony J
    Ther Hung; 1975; 23(2):54-9. PubMed ID: 1188703
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determinations of clinical variations and lipid metabolism in patients with chronic ischemia of the lower extremities by means of a pentosan sulfonic ester and xanthinol niacinate combination].
    González González M; Azcona Elizalde JM; Lorente Navarro MC; Duato Jane A
    Angiologia; 1979; 31(4):180-4. PubMed ID: 382919
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transcutaneous oxygen pressure during intra-arterial infusions].
    Creutzig A; Dau D; Alexander K
    Vasa; 1984; 13(3):207-12. PubMed ID: 6485524
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of complamin in nephrological practice].
    Mamikonian RS; Barsegian BA; Tumanian AM; Arutiunian VM; Basmadzhian NM
    Zh Eksp Klin Med; 1979; 19(4):62-7. PubMed ID: 506579
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
    Benignetti G; Fabbri F; Benvenuti C
    Clin Ter; 1983 Feb; 104(4):297-304. PubMed ID: 6861465
    [No Abstract]   [Full Text] [Related]  

  • 10. [Complamin in the complex therapy of patients with chronic nonspecific prostatitis].
    Iunda IF; Israilov SR
    Vrach Delo; 1987 Nov; (11):64-7. PubMed ID: 3439130
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cosaldon retard in the treatment of optic neuritis and macular degeneration].
    Myszka A
    Klin Oczna; 1979; 81(2):161-2. PubMed ID: 439725
    [No Abstract]   [Full Text] [Related]  

  • 12. Xanthinol nicotinate in peripheral vascular disease.
    Davis E; Rozov H
    Practitioner; 1975 Dec; 215(1290):793-8. PubMed ID: 772653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of complamin in some dermatoses].
    Verbenko EV; Goncharova LI; Petrova IL; Shamina GE
    Vestn Dermatol Venerol; 1975 Aug; (8):77-80. PubMed ID: 126606
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bioavailability and tolerance of xanthinol nicotinate depot preparations. Comparison of a conventional 500 mg xanthinol nicotinate depot tablet with new 500 mg and 1 g depot tablets].
    von Schrader HW; Buscher G; Dierdorf D; Freytag A; Mügge H; Wolf D
    Arzneimittelforschung; 1985; 35(9):1468-72. PubMed ID: 4084347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human placental lactogen (HPL) levels in the maternal serum following long-term intake of xantinol nicotinate (Complamin Retard) (author's transl)].
    Sérey CT; Saling E
    Z Geburtshilfe Perinatol; 1980 Aug; 184(4):283-9. PubMed ID: 7008399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of xavin in vascular diseases of the lower extremities].
    Volgin EG
    Klin Med (Mosk); 1980 Oct; 58(10):46-50. PubMed ID: 7442096
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of xanthinol nicotinate in patients with chronic ischemic heart disease].
    Sivkov II; Kukes VG; Borisov VG; Rudakov MA; Blistanova LS
    Ter Arkh; 1977; 49(1):30-3. PubMed ID: 867235
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of trental and complamine in the microcirculatory disorders of diabetes mellitus].
    Spesivtseva VG; Kasabian IN; Mamaeva GG; Kukes VG
    Sov Med; 1980; (2):64-9. PubMed ID: 6987747
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complamine in combination with methionine in the treatment of parapsoriasis].
    Orazymbetova ZhA
    Vestn Dermatol Venerol; 1978 Mar; (3):65-8. PubMed ID: 654516
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of complamin on the systemic and cerebral hemodynamics of atherosclerosis patients with chronic cerebral vascular disorders].
    Ishchenko MM; Dorogiĭ AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(1):59-65. PubMed ID: 3984595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.